Kun Cheng

5.6k total citations · 1 hit paper
102 papers, 4.4k citations indexed

About

Kun Cheng is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Kun Cheng has authored 102 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 26 papers in Oncology and 23 papers in Surgery. Recurrent topics in Kun Cheng's work include RNA Interference and Gene Delivery (27 papers), Liver physiology and pathology (17 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Kun Cheng is often cited by papers focused on RNA Interference and Gene Delivery (27 papers), Liver physiology and pathology (17 papers) and Advanced biosensing and bioanalysis techniques (14 papers). Kun Cheng collaborates with scholars based in United States, China and Australia. Kun Cheng's co-authors include Wanyi Tai, Rubi Mahato, Akshay Jain, Zhen Zhao, Hao Liu, Li Zhang, Ram I. Mahato, Chang Liu, Ashutosh Barve and Bin Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemistry and Cancer Research.

In The Last Decade

Kun Cheng

96 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

2017 443 citations Chang Liu, Li Zhang et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Kun Cheng

Since Specialization

Citations

This map shows the geographic impact of Kun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Cheng more than expected).

Fields of papers citing papers by Kun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Cheng. The network helps show where Kun Cheng may publish in the future.

Co-authorship network of co-authors of Kun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Cheng. A scholar is included among the top collaborators of Kun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Cheng. Kun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis 2025 ·Journal of Controlled Release ·(unknown), Zhen Zhao, Yuanke Li, Yanli Liu, Yuanyuan Zhang, Kun Cheng	3
2	Preparation, Characterization and Bioactivities of Strawberry Polysaccharides 2025 ·Foods ·(unknown), Yumeng Zhao, (unknown), (unknown), Yanhui Wei, Kun Cheng, Yaqin Xu	0
3	Influence of preoperative HbA1c levels on the occurrence of postoperative complications in patients undergoing coronary artery bypass grafting 2024 ·Journal of Cardiothoracic Surgery ·Bing Liu, Zi Li, Xueqing Chen, Sheng Wang, Kun Cheng	0
4	Enhancing the imidase activity of BpIH toward 3-isobutyl glutarimide via semi-rational design 2024 ·Applied Microbiology and Biotechnology ·Wenping Qin, (unknown), Kun Cheng, Yinhua Lü, (unknown)	0
5	Therapeutic Benefits of Stem Cells and Exosomes for Sulfur-Mustard-Induced Tissue Damage 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Pengfei Yu, Kun Cheng, Sean V. Murphy, Patrick McNutt, (unknown)	5
6	A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance 2023 ·Cancer Letters ·Jing Zhou, (unknown), Qiongling Wang, Ming Yang, Eric T. Kimchi, Kun Cheng, Trupti Joshi, (unknown), Kevin F. Staveley-O’Carroll, Guangfu Li	34
7	Recent advances in the development of therapeutic peptides 2023 ·Trends in Pharmacological Sciences ·John Fetse, (unknown), (unknown), Kun Cheng	71
8	Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record 2021 ·International Journal of COPD ·Meng Li, Kun Cheng, (unknown), Junlei Li, Hao Hu, Carolina Oi Lam Ung	10
9	Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response 2020 ·Journal for ImmunoTherapy of Cancer ·Xiaoqiang Qi, Ming Yang, Lixin Ma, (unknown), Diego M. Avella, Jussuf T. Kaifi, Jeffrey N. Bryan, Kun Cheng, Kevin F. Staveley-O’Carroll, Eric T. Kimchi, Guangfu Li	75
10	Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy 2020 ·Acta Biomaterialia ·Ashutosh Barve, Akshay Jain, Hao Liu, Zhen Zhao, Kun Cheng	92
11	Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications breakdown → 2017 ·Journal of Controlled Release ·Chang Liu, Li Zhang, Hao Liu, Kun Cheng	443
12	Discovery of PSMA-specific peptide ligands for targeted drug delivery 2016 ·International Journal of Pharmaceutics ·Wei Jin, Bin Qin, Zhijin Chen, Hao Liu, Ashutosh Barve, Kun Cheng	43
13	Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Ravi Shukla, Akshay Jain, Zhen Zhao, Kun Cheng	48
14	Targeted Nanodiamonds as Phenotype-Specific Photoacoustic Contrast Agents for Breast Cancer 2015 ·Nanomedicine ·Ti Zhang, Huizhong Cui, Chia‐Yi Fang, Kun Cheng, Xinmai Yang, Huan‐Cheng Chang, M. Laird Forrest	33
15	A Novel Rapamycin-Polymer Conjugate Based on a New Poly(Ethylene Glycol) Multiblock Copolymer 2013 ·Pharmaceutical Research ·Wanyi Tai, Zhijin Chen, Ashutosh Barve, Zhonghua Peng, Kun Cheng	24
16	Mesenchymal stem cell–conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation 2013 ·Journal of Surgical Research ·Zhiyong Du, (unknown), Kun Cheng, Baosan Han, Jiqi Yan, Mingjun Zhang, Chenghong Peng, Yingbin Liu	78
17	Development of a Peptide–Drug Conjugate for Prostate Cancer Therapy 2011 ·Molecular Pharmaceutics ·Wanyi Tai, Ravi Shukla, Bin Qin, Benyi Li, Kun Cheng	76
18	Inhibition of Breast Cancer Cell Growth and Invasiveness by Dual Silencing of HER-2 and VEGF 2010 ·Molecular Pharmaceutics ·Wanyi Tai, Bin Qin, Kun Cheng	39
19	Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice 2010 ·Diabetologia ·(unknown), Shu Lin, (unknown), Kun Cheng, Paul A. Baldock, (unknown), Mark McLean, N. Wah Cheung, Amanda Sainsbury, Frank J. Gonzalez, Herbert Herzog, Jenny E. Gunton	16
20	Adenovirus-based vascular endothelial growth factor gene delivery to human pancreatic islets 2004 ·Gene Therapy ·Kun Cheng, Daniel Fraga, (unknown), Malak Kotb, A. Osama Gaber, R V Guntaka, Ram I. Mahato	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact